• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Circulating osteogenic precursor cells in heterotopic bone formation.异位骨形成中循环成骨前体细胞
Stem Cells. 2009 Sep;27(9):2209-19. doi: 10.1002/stem.150.
2
Hematopoietic stem-cell contribution to ectopic skeletogenesis.造血干细胞对异位骨骼生成的贡献。
J Bone Joint Surg Am. 2007 Feb;89(2):347-57. doi: 10.2106/JBJS.F.00472.
3
Circulating osteogentic precursor cells in non-hereditary heterotopic ossification.非遗传性异位骨化中的循环成骨前体细胞。
Bone. 2018 Apr;109:61-64. doi: 10.1016/j.bone.2017.12.028. Epub 2018 Jan 3.
4
Role for circulating osteogenic precursor cells in aortic valvular disease.循环成骨前体细胞在主动脉瓣疾病中的作用。
Arterioscler Thromb Vasc Biol. 2011 Dec;31(12):2965-71. doi: 10.1161/ATVBAHA.111.234724. Epub 2011 Sep 8.
5
BMP-dependent, injury-induced stem cell niche as a mechanism of heterotopic ossification.BMP 依赖性、损伤诱导的干细胞龛作为异位骨化的机制。
Stem Cell Res Ther. 2019 Jan 11;10(1):14. doi: 10.1186/s13287-018-1107-7.
6
Cartilage-derived retinoic acid-sensitive protein (CD-RAP): A stage-specific biomarker of heterotopic endochondral ossification (HEO) in fibrodysplasia ossificans progressiva (FOP).软骨源性维甲酸敏感蛋白 (CD-RAP):成纤维细胞性骨化发育不良进展期 (FOP) 异位软骨内骨化 (HEO) 的阶段特异性生物标志物。
Bone. 2018 Apr;109:153-157. doi: 10.1016/j.bone.2017.09.016. Epub 2017 Sep 28.
7
Retinoid roles and action in skeletal development and growth provide the rationale for an ongoing heterotopic ossification prevention trial.视黄酸在骨骼发育和生长中的作用和作用为正在进行的异位骨化预防试验提供了依据。
Bone. 2018 Apr;109:267-275. doi: 10.1016/j.bone.2017.08.010. Epub 2017 Aug 19.
8
Depletion of Mast Cells and Macrophages Impairs Heterotopic Ossification in an Acvr1 Mouse Model of Fibrodysplasia Ossificans Progressiva.破骨细胞和巨噬细胞耗竭可损害 Acvr1 小鼠纤维性骨发育不良进展性异位骨化模型中的异位骨化。
J Bone Miner Res. 2018 Feb;33(2):269-282. doi: 10.1002/jbmr.3304. Epub 2018 Jan 3.
9
Heterotopic Ossification in Mouse Models of Fibrodysplasia Ossificans Progressiva.进行性骨化性纤维发育不良小鼠模型中的异位骨化
Methods Mol Biol. 2019;1891:247-255. doi: 10.1007/978-1-4939-8904-1_18.
10
Identification of progenitor cells that contribute to heterotopic skeletogenesis.对促成异位骨骼形成的祖细胞的鉴定。
J Bone Joint Surg Am. 2009 Mar 1;91(3):652-63. doi: 10.2106/JBJS.H.01177.

引用本文的文献

1
Erroneous Differentiation of Tendon Stem/Progenitor Cells in the Pathogenesis of Tendinopathy: Current Evidence and Future Perspectives.肌腱病发病机制中肌腱干/祖细胞的错误分化:当前证据与未来展望
Stem Cell Rev Rep. 2025 Feb;21(2):423-453. doi: 10.1007/s12015-024-10826-z. Epub 2024 Nov 23.
2
Analysis of circulating osteoclast and osteogenic precursors in patients with Gorham-Stout disease.戈勒姆-斯托特病患者循环破骨细胞和成骨前体细胞分析。
J Endocrinol Invest. 2024 Nov;47(11):2775-2784. doi: 10.1007/s40618-024-02365-8. Epub 2024 Apr 1.
3
Navigating the Complex Landscape of Fibrodysplasia Ossificans Progressiva: From Current Paradigms to Therapeutic Frontiers.探索进行性骨化性纤维发育不良的复杂领域:从现有范式到治疗前沿。
Genes (Basel). 2023 Nov 30;14(12):2162. doi: 10.3390/genes14122162.
4
Number of contiguous vertebral cross-links in the spine indicates bone formation: a cross-sectional study.脊柱连续椎体交叉数表示骨形成:一项横断面研究。
BMC Musculoskelet Disord. 2023 Sep 15;24(1):736. doi: 10.1186/s12891-023-06833-9.
5
Circulating Osteoprogenitor Cells Have a Mixed Immune and Mesenchymal Progenitor Function in Humans.循环骨祖细胞在人类中具有混合的免疫和间充质祖细胞功能。
Stem Cells. 2023 Nov 5;41(11):1060-1075. doi: 10.1093/stmcls/sxad064.
6
New perspective of skeletal stem cells.骨骼干细胞的新视角。
Biomater Transl. 2022 Dec 28;3(4):280-294. doi: 10.12336/biomatertransl.2022.04.007. eCollection 2022.
7
Circulating biomarkers for diagnosis and therapeutic monitoring in bone metastasis.循环生物标志物在骨转移中的诊断和治疗监测。
J Bone Miner Metab. 2023 May;41(3):337-344. doi: 10.1007/s00774-022-01396-6. Epub 2023 Feb 2.
8
Assessment of the Necessity of Osteoporosis Treatment for Patients with Low Bone Density in Diffuse Idiopathic Skeletal Hyperostosis.弥漫性特发性骨肥厚中骨密度低的患者骨质疏松症治疗必要性的评估
Spine Surg Relat Res. 2022 Apr 12;6(5):526-532. doi: 10.22603/ssrr.2021-0149. eCollection 2022 Sep 27.
9
Pathophysiology and Emerging Molecular Therapeutic Targets in Heterotopic Ossification.异位骨化的病理生理学和新兴分子治疗靶点。
Int J Mol Sci. 2022 Jun 23;23(13):6983. doi: 10.3390/ijms23136983.
10
Overexpression of Wild-Type ACVR1 in Fibrodysplasia Ossificans Progressiva Mice Rescues Perinatal Lethality and Inhibits Heterotopic Ossification.野生型 ACVR1 在进行性骨化性纤维发育不良小鼠中的过表达可挽救围产期致死性并抑制异位骨化。
J Bone Miner Res. 2022 Nov;37(11):2077-2093. doi: 10.1002/jbmr.4617. Epub 2022 Jul 3.

本文引用的文献

1
Identification of progenitor cells that contribute to heterotopic skeletogenesis.对促成异位骨骼形成的祖细胞的鉴定。
J Bone Joint Surg Am. 2009 Mar 1;91(3):652-63. doi: 10.2106/JBJS.H.01177.
2
Classic and atypical fibrodysplasia ossificans progressiva (FOP) phenotypes are caused by mutations in the bone morphogenetic protein (BMP) type I receptor ACVR1.典型和非典型进行性骨化性纤维发育不良(FOP)表型是由骨形态发生蛋白(BMP)I型受体ACVR1中的突变引起的。
Hum Mutat. 2009 Mar;30(3):379-90. doi: 10.1002/humu.20868.
3
BMP type I receptor inhibition reduces heterotopic [corrected] ossification.骨形态发生蛋白I型受体抑制可减少异位骨化。 (注:原文中“heterotopic [corrected] ossification”可能有误,推测应为“heterotopic ossification”,即异位骨化,这里按照推测后的正确内容进行了翻译)
Nat Med. 2008 Dec;14(12):1363-9. doi: 10.1038/nm.1888. Epub 2008 Nov 30.
4
Osteocalcin expression by circulating endothelial progenitor cells in patients with coronary atherosclerosis.冠状动脉粥样硬化患者循环内皮祖细胞的骨钙素表达
J Am Coll Cardiol. 2008 Oct 14;52(16):1314-25. doi: 10.1016/j.jacc.2008.07.019.
5
Identification of white adipocyte progenitor cells in vivo.体内白色脂肪细胞祖细胞的鉴定。
Cell. 2008 Oct 17;135(2):240-9. doi: 10.1016/j.cell.2008.09.036. Epub 2008 Oct 2.
6
Dysregulation of local stem/progenitor cells as a common cellular mechanism for heterotopic ossification.局部干/祖细胞失调作为异位骨化的一种常见细胞机制。
Stem Cells. 2009 Jan;27(1):150-6. doi: 10.1634/stemcells.2008-0576.
7
Fibrocytes are a potential source of lung fibroblasts in idiopathic pulmonary fibrosis.纤维细胞是特发性肺纤维化中肺成纤维细胞的一个潜在来源。
Int J Biochem Cell Biol. 2008;40(10):2129-40. doi: 10.1016/j.biocel.2008.02.012. Epub 2008 Mar 11.
8
HIF1alpha induces the recruitment of bone marrow-derived vascular modulatory cells to regulate tumor angiogenesis and invasion.缺氧诱导因子1α(HIF1α)诱导骨髓来源的血管调节细胞募集,以调节肿瘤血管生成和侵袭。
Cancer Cell. 2008 Mar;13(3):206-20. doi: 10.1016/j.ccr.2008.01.034.
9
Circulating fibrocytes: cellular basis for NSF.循环纤维细胞: NSF的细胞基础
J Am Coll Radiol. 2008 Jan;5(1):36-9. doi: 10.1016/j.jacr.2007.08.016.
10
Bone marrow-derived circulating progenitor cells fail to transdifferentiate into adipocytes in adult adipose tissues in mice.在小鼠成年脂肪组织中,骨髓来源的循环祖细胞无法转分化为脂肪细胞。
J Clin Invest. 2007 Dec;117(12):3684-95. doi: 10.1172/JCI32504.

异位骨形成中循环成骨前体细胞

Circulating osteogenic precursor cells in heterotopic bone formation.

作者信息

Suda Robin K, Billings Paul C, Egan Kevin P, Kim Jung-Hoon, McCarrick-Walmsley Ruth, Glaser David L, Porter David L, Shore Eileen M, Pignolo Robert J

机构信息

Department of Medicine, University of Pennsylvania, School of Medicine, Philadelphia, Pennsylvania 19104-6160, USA.

出版信息

Stem Cells. 2009 Sep;27(9):2209-19. doi: 10.1002/stem.150.

DOI:10.1002/stem.150
PMID:19522009
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3496263/
Abstract

Cells with osteogenic potential can be found in a variety of tissues. Here we show that circulating osteogenic precursor (COP) cells, a bone marrow-derived type I collagen+/CD45+ subpopulation of mononuclear adherent cells, are present in early preosseous fibroproliferative lesions in patients with fibrodysplasia ossificans progressiva (FOP) and nucleate heterotopic ossification (HO) in a murine in vivo implantation assay. Blood samples from patients with FOP with active episodes of HO contain significantly higher numbers of clonally derived COP cell colonies than patients with stable disease or unaffected individuals. The highest level of COP cells was found in a patient just before the clinical onset of an HO exacerbation. Our studies show that even COP cells derived from an unaffected individual can contribute to HO in genetically susceptible host tissue. The possibility that circulating, hematopoietic-derived cells with osteogenic potential can seed inflammatory sites has tremendous implications and, to our knowledge, represents the first example of their involvement in clinical HO. Thus, bone formation is not limited to cells of the mesenchymal lineage, and circulating cells of hematopoietic origin can also serve as osteogenic precursors at remote sites of tissue inflammation.

摘要

具有成骨潜能的细胞存在于多种组织中。在此我们表明,循环成骨前体细胞(COP细胞),即一种源自骨髓的I型胶原阳性/CD45阳性单核贴壁细胞亚群,在进行性骨化性纤维发育不良(FOP)患者的早期骨前纤维增殖性病变中存在,并且在小鼠体内植入试验中可形成异位骨化(HO)。处于HO活动期的FOP患者的血样中,克隆衍生的COP细胞集落数量显著高于病情稳定的患者或未受影响的个体。在一名HO加重临床发作前的患者中发现了最高水平的COP细胞。我们的研究表明,即使是源自未受影响个体的COP细胞,也可在基因易感的宿主组织中促成HO。具有成骨潜能的循环造血来源细胞能够在炎症部位着床,这一可能性具有重大意义,据我们所知,这代表了它们参与临床HO的首个实例。因此,骨形成并不局限于间充质谱系的细胞,造血来源的循环细胞也可在组织炎症的远处部位充当成骨前体。